[HTML][HTML] Potential mechanisms of action for vitamin C in cancer: reviewing the evidence

MCM Vissers, AB Das - Frontiers in physiology, 2018 - frontiersin.org
Whether vitamin C (ascorbate) has a role to play as an anti-cancer agent has been debated
for decades. Ascorbate has been used by cancer patients in an unregulated environment …

[HTML][HTML] Prognostic significance of carbonic anhydrase IX expression in cancer patients: a meta-analysis

SJA van Kuijk, A Yaromina, R Houben… - Frontiers in …, 2016 - frontiersin.org
Hypoxia is a characteristic of many solid tumors and an adverse prognostic factor for
treatment outcome. Hypoxia increases the expression of carbonic anhydrase IX (CAIX), an …

Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer: a systematic review

S Chatterji, E Krzoska, CW Thoroughgood… - The Lancet …, 2023 - thelancet.com
Although similar phenotypically, there is evidence that male and female breast cancer differ
in their molecular landscapes. In this systematic review, we consolidated all existing …

[HTML][HTML] Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels

EJ Campbell, GU Dachs, HR Morrin, VC Davey… - BMC cancer, 2019 - Springer
Background The transcription factor hypoxia inducible factor (HIF)-1 drives tumor growth and
metastasis and is associated with poor prognosis in breast cancer. Ascorbate can moderate …

Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers

M Andrea, T Weinschenk, V Goldfinger… - US Patent …, 2019 - Google Patents
The present invention relates to peptides, proteins, nucleic acids and cells for use in
immunotherapeutic methods. In particular, the present invention relates to the immuno …

Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers

A Mahr, T Weinschenk, V Goldfinger, O Schoor… - 2018 - Google Patents
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C ([C@ H](NC (=
O)[C@ H](C (C) C) NC (= O) CNC (= O)[C@ H](CCC (O)= O) NC (= O)[C@ H](CCCNC (N) …

[HTML][HTML] Metabolism and immunity in breast cancer

D Zhang, X Xu, Q Ye - Frontiers of medicine, 2021 - Springer
Breast cancer is one of the most common malignancies that seriously threaten women's
health. In the process of the malignant transformation of breast cancer, metabolic …

[HTML][HTML] Male breast cancer: from molecular genetics to clinical management

M Pensabene, C Von Arx, M De Laurentiis - Cancers, 2022 - mdpi.com
Simple Summary Male breast cancer (MBC) is a rare disease. Genetic factors predispose to
male breast cancer. Germline and/or genetic and/or epigenetic alterations at the somatic …

The cancer genetics and pathology of male breast cancer

S Deb, SR Lakhani, L Ottini, SB Fox - Histopathology, 2016 - Wiley Online Library
Male breast cancer (MBC) is an uncommon and poorly understood disease. Recent
molecular studies have shown important differences from female breast cancer which are …

High expression of HIF-1α, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis

S Thongchot, P Yongvanit, W Loilome… - Asian Pacific Journal …, 2014 - koreascience.kr
Hypoxia and autophagy are known to facilitate tumor progression. We here aimed to
investigate the role of hypoxia-associated autophagy in cholangiocarcinoma (CCA) survival …